FDA Investigator Neal L Adams

Neal L Adams has inspections in 9 countries as of 13 Sep 2023. Neal L Adams has collaborated with a combinined 3253 experts on various inspections, contributing to compliance and improvement across diverse sectors.

Investigator Details

Number of Inspected Sites:
23
Last Inspection Date:
13 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
100006091
Country:
France, India, United States of America, Germany, Ireland, China, Singapore, Norway, Taiwan
Co-Investigator(s):
Adam R Cooke, Alan E Mehl, Alan L Brend, Alan L Truong, Albinus M D Sa, Amy E Devine, Anita Narula, PhD, Anita R Michael, Ann L Demarco, Anthony R Bucks, Aref M El Demerdash, Arthur S Williams, Jr, Ashar P Parikh, Barbara L Rogolsky, Bijoy Panicker, Brandon C Heitmeier, Brenda C Hamilton, Brenda W Uratani, PhD, Brett R Havranek, Brittany D Terhar, Bryan A Galvez, Bryan S Roddy, Burnell M Henry, Carl A Huffman, III, Carl J Montgomery, Carl Lee, Charles M Edwards, Charles R Cote, RIC, Chilton L Ng, Chris A Sack, Christina Capacci Daniel, PhD, Christopher T Peters, Cody D Rickman, Concepcion Cruz, Jr, Constance Y Fears, Cynthia L Evitt, Cynthia M Godeau, Cynthia M Goudeau, Danial S Hutchison, Daniel R Hurt, David A Place, David J Eide, David J Gomes, Diane L Raccasi, Douglas C Kovacs, Dr. Sriram Subramaniam, PhD, Edward E Lockwood (EEL), Emest F Bizjak, Eric M Mueller, PharmD, Eric M Padgett, Erika V Butler, Evelyne L Weaver, Farhana Khan, Felix Maldonado, Gayle S Lawson, Gretchen Lf Trendel, Gwyn G Dickinson, Ingrid Y Johnson, J Michael Cannon, PhD, James C Maclaughlin, James D Planchon, James I Giefer, James L Dunnie, Jr, Javier O Vega, Jawaid Hamid, Jeannie M Vonderbrink, Jeffrey A Sommers, Jill J Tillman, Joey V Quitania, Jose Acruz Gonzalez, Jose M Cayuela, Jose R Hernandez, Jose Velez, Joseph R Lambert, Julie N Vosilus, Karen C Daugherty, Kejun Cheng, Kellia N Hicks, Kelvin Cheung, Kham Phommachanh, Kim Lthomas Cruse, Kimberly Lewandowski Walker, LCDR Debra Emerson, Linda Kuchanthal, Linda R Kuchenthal, Lisa L Flores, Lisa L Gilliam, LT Richard A Lyght, Marcus F Yambot, Maria Estrella, Marijo B Kambere, PhD, Marion D Wimberly, Jr, Mark S Ross, Martin K Yau, PhD, Matthew D Schnittker, Matthew H Hunt, Matthew R Sleeter, Megan M Kirk, Michael A Charles, Michael C Zubelewicz, Michael D Smedley, Michael E Maselli, Michael R Klapal, Michael S Smoker, Michael Shanks, MS, Michele L Forster, PhD, Michele L Obert, Michele Perry Williams, Miguel A Martinez, Mindy M Chou, Minerva Rogers, Miranda D Mcdonald, Monique M Brooks, Mra B Kamberem, Mra Davism, Muralidhara B Gavini, PhD, Nancy G Schmidt, Omotunde O Osunsanmi, Pamela N Agaba, Patrick L Wisor, Paul E Stein, Peter C Chow, Peter E Baker, Prabhu P Raju, Pratik S Upadhyay, DDC, Rachel Collen, Ralph H Vocque, Ralph Jerndal, Randy D Moore, Raymond Valdivia, Rebecca Rodriguez, Regina T Brown, Richard K Vogel, Rita K Kabaso, Robert J Ham, Robin K Hatfield, Robin K Reel, Rodney D Combs, Rosanna M Goodrich, Ruth Moore, PhD, Samuel K Gibbons, Jr, Santos E Camara, Seneca D Toms, Shafiq S Ahadi, Sharon K Thoma, PharmD, Shawn E Larson, Shirley J Berryman, Shirley J Burryman, Shwnji Susie Lee, Sony Mathews, Stacie A Woods, Stephen C Smith, Stephen D Brown, Stephen J Kilker, Steven D Kehoe, Steven Fong, MS, PhD, Susan F Laska, MS, Susanna E Ford, Analyst, Susant Hadman, Susie H Lee, Tamara J Umscheid, Tara L Breckenridge, Tara L Greene, Tara L King, Thomas J Arista, Tonya R Johnson, Torrey M Ward, Travis S Bradley, Veronica Fuentes, MS, Victoria A Wagoner, Vinh T Phan, Warren J Lopicka, Wayne D Mcgrath, Wendy G Tan, PhD, Xiaokuang Lai, PhD, Yehualashet A Gessesse, Yumi J Hiramine, Yvins Dezan, Zachary A Bogorad, Zhihao Qiu (Peter), PhD, Zhong Li, PhD, Zi Qiang Gu

Neal L Adams's Documents

Publish Date Document Type Title
April, 2014 FDA 483 HIKAL LIMITED - Form 483, 2014-04-11
January, 2008 FDA 483 Teva Pharmaceuticals USA Inc - Form 483, 2008-01-18
November, 2005 EIR Catalent CTS, LLC - EIR, 2005-11-22
April, 2004 EIR Catalent CTS, LLC - EIR, 2004-04-02

Experience Redica System's NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more